MedTrace Logo

Management of Nausea and Vomiting Chemotherapy-induced in Normandy

NCT01440465 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-12-17

Study results available
· View outcomes & findings →

Summary

The objective of this study was to evaluate the various parameters involved in the occurrence of nausea / vomiting during the first cycle of chemotherapy for solid tumors or hematologic among a group of chemotherapy-naive patients, despite anti standardized-emetics protocols.

Conditions

Sponsors & Collaborators

  • Centre Francois Baclesse

    lead OTHER

Principal Investigators

  • JOLY Florence, Pr · Centre François Baclesse

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2013-01-31
Completion
2013-02-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01440465 on ClinicalTrials.gov